This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Announces Revamped Mosby's Index

PHILADELPHIA, May 9, 2013 /PRNewswire/ --

New version offers nurses, librarians and researchers a powerful connection to evidence-based content

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the revamping of Mosby's Index, the most robust journal abstracts and indexing database available for nurses and other healthcare professionals. Offering a broad range of unique content and search results from more than 3,150 international source titles, Mosby's Index is now in an easier-to-navigate format with more searching power.

Mosby's Index is part of Mosby's Suite, which connects clinicians to authoritative information and powerful technology to provide the resources necessary to consistently provide optimal patient care.

"As a leader in educating healthcare professionals, we understand the tools necessary for nurses, clinicians, and librarians to do their jobs thoroughly and effectively," said Cindy Tryniszewski, RN, MSN, Executive Director, Mosby's eLearning for Elsevier. "With this redesigned Mosby's Index, we've ramped up the power of the searches and are providing a tool that is easier for all users to navigate and leverage for their research needs."

The new Mosby's Index offers a simple, intuitive interface, filters to narrow search results, and easier access to Drug and Disease Subheadings, among other enhancements. It also includes improved timesaving tools such as email alerts, saved searches and the capability to share search results.

"The filters, adjustable time frame, [and] choice of search are all easier ways to start a search for particular articles and research items," said Sandra Beta, MSN, RN, OCN, Nursing/Nurse Educator at Cancer Treatment Centers of America ®. Kristie Saumure, a reference librarian at a government health organization, added, "I found it very easy and straightforward to find all of the tools needed to complete my search."

For more information about please visit http://confidenceconnected.com/newindex or call + 1 866 416 6697.

About Elsevier

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs